Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
about
Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Lemborexant, A Dual Orexin Rec ...... ind, Placebo-Controlled Study.
@en
Lemborexant, A Dual Orexin Rec ...... ind, Placebo-Controlled Study.
@nl
type
label
Lemborexant, A Dual Orexin Rec ...... ind, Placebo-Controlled Study.
@en
Lemborexant, A Dual Orexin Rec ...... ind, Placebo-Controlled Study.
@nl
prefLabel
Lemborexant, A Dual Orexin Rec ...... ind, Placebo-Controlled Study.
@en
Lemborexant, A Dual Orexin Rec ...... ind, Placebo-Controlled Study.
@nl
P2093
P2860
P356
P1476
Lemborexant, A Dual Orexin Rec ...... ind, Placebo-Controlled Study.
@en
P2093
Andrew Satlin
David Mayleben
Gary Zammit
Kate Pinner
Luigi Giorgi
Margaret Moline
Patricia Murphy
Russell Rosenberg
Shobha Dhadda
P2860
P304
P356
10.5664/JCSM.6800
P407
P577
2017-11-15T00:00:00Z